Latest: FDA Approves New Biosimilar for Oncology Treatment

CMMI Puts Early EOM Data Online, to Surprise of Participants

Under the second Trump administration, CMMI has published far more detail about peformance of Enhancing Oncology Model participants than under an earlier model, which spanned the administrations of 3 presidents.
Tags:
📢

Advertisement

300x250 Banner

Recent Content

COPD Biologics: Early Treatment Insights

Pulmonology • 2 hours ago

Antihypertensive Medication Guidelines

Cardiology • 4 hours ago

Juvenile Arthritis Care Transition

Rheumatology • 6 hours ago